We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > KEPTIDE

News List

Sotira Completes Pre-Clinical Testing for COVID-19 Vaccine Alternative americanpharmaceuticalreview
December 09, 2020
Sotira has announced the successful completion of the second phase of pre-clinical testing for its COVID-19 therapeutic and vaccine-alternative, KEPTIDE™ COVID, confirming this molecular therapy completely prevented the entry of SARS-CoV2 in the lungs ...
Arizona BioTech Company Successfully Completes Pre-Clinical Testing for Vaccine Alternative to Prevent COVID-19 Infection, Ready for Human Trials prnewswire
November 24, 2020
Sotira, the Phoenix based biotech company, is pleased to announce the successful completion of the second phase of pre-clinical testing for its COVID-19 therapeutic and vaccine-alternative, KEPTIDE™ COVID, confirming that this cutting-edge molecular ...
Sotira Finds Preliminary Success Developing Intranasal COVID-19 Vaccine Alternative americanpharmaceuticalreview
October 29, 2020
Sotira has announced preliminary findings of preclinical safety and efficacy studies for its patent-pending vaccine alternative that has shown in on-going preclinical testing to attenuate COVID-19 infection.